News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Whole-Patient Care Cannot be an Afterthought – European Cancer Organisation
European Cancer Organisation/LinkedIn
May 16, 2025, 10:25

Whole-Patient Care Cannot be an Afterthought – European Cancer Organisation

European Cancer Organisation shared a post on LinkedIn:

“New Community 365 Roundtable – Join the Conversation!

Are we truly treating the whole cancer patient?

As Sir William Osler often said:

‘The good physician treats the disease; the great physician treats the patient who has the disease.’

In our upcoming Community 365 Roundtable, we’ll explore often overlooked but vital aspects of comprehensive cancer care:

  • Antimicrobial resistance (AMR).
  • Medical nutrition.
  • Patient Safety.

-Tuesday, 27 May
-15:00–17:30 CEST
-Online

This timely discussion will be co-chaired by:

  • Prof. Alessandro Laviano, an associate professor at Sapienza University of Rome and the director of ESPEN – European Society for Clinical Nutrition and Metabolism Lifelong Learning Educational Programme.
  • Ivana Dragojević, president of the Association for Liver Diseases Hronos and the vice-president of the European Liver Patients’​ Association – ELPA.

Whole-patient care cannot be an afterthought. We need to make it a priority!

Register now and join the conversation!”

More posts featuring European Cancer Organisation.

Alessandro Laviano AMR antimicrobial resistance Association for Liver Diseases Hronos cancer cancer care Community 365 Roundtable ECO ELPA ESPEN European Cancer Organisation European Liver Patients'​ Association European Society for Clinical Nutrition fight against cancer Global fight against cancer Ivana Dragojević OncoDaily Oncology patient care Sapienza University of Rome William Osler
Special Coverage
Blog
May 16, 2025, 11:26
Antonio Giordano: Important question - which 1L CDK4/6i to preserve efficacy of re-cycling cell cycle in 2L?
Oncolibrary
May 16, 2025, 11:22
FDA Approves Belzutifan (Welireg) for Advanced Pheochromocytoma and Paraganglioma: Results of LITESPARK-015 Trial
Blog
May 16, 2025, 10:40
€1 Million Innovation Grant Awarded to Joshua Waterfall for Pediatric Cancer Research - KickCancer
Blog
May 16, 2025, 10:25
Whole-Patient Care Cannot be an Afterthought - European Cancer Organisation
Blog
May 16, 2025, 10:07
A Conversation Centered on AI, Early Detection, and Breakthrough Therapies Shaping the Future of Oncology - Dana-Farber Cancer Institute
Blog
May 16, 2025, 09:56
Use of Food Restrictions to Prevent Infections in Paediatric Patients with Cancer and Haematopoietic Cell Transplantation Recipients - MASCC
Blog
May 16, 2025, 09:43
Lynn Schuchter on Skin Cancer Care and Importance of Investing in Research to Improve Patient Outcomes - Conquer Cancer
Blog
May 16, 2025, 09:33
Triparna Sen: Have You Cast Your Vote Yet for the 2025 IASLC Board of Directors Election?
Insight
May 16, 2025, 09:25
New World Cancer Declaration 2025–2035 by UICC
Blog
May 16, 2025, 09:25
Leveraging technology to improve cross-stakeholder collaboration and patient outcomes - CancerX
Blog
May 16, 2025, 09:10
Jasmine Kamboj: Join us For an Engaging Session on POLICY at ASCO25
Blog
May 16, 2025, 09:09
Aman Chauhan Congratulates Taymeyah Al-Toubah and Colleagues on Launching Clinical Trial Files Podcast